{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:30:09Z","timestamp":1747801809737,"version":"3.41.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Evidera"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13555-025-01406-1","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:23:46Z","timestamp":1745389426000},"page":"1405-1426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04501666","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04501679","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-7786","authenticated-orcid":false,"given":"Sonja","family":"St\u00e4nder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-6999","authenticated-orcid":false,"given":"Danielle N.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4701-8825","authenticated-orcid":false,"given":"Carla","family":"Dias-Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-4367","authenticated-orcid":false,"given":"Dina","family":"Filipenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-1252","authenticated-orcid":false,"given":"Jorge","family":"Puelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-8263","authenticated-orcid":false,"given":"Zarif K.","family":"Jabbar-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9969-2478","authenticated-orcid":false,"given":"Christophe","family":"Piketty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-8600","authenticated-orcid":false,"given":"Henning","family":"Wiegmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-1515","authenticated-orcid":false,"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"4","key":"1406_CR1","first-page":"97","volume":"6","author":"CD Kwon","year":"2019","unstructured":"Kwon CD, Khanna R, Williams KA, Kwatra MM, Kwatra SG. Diagnostic workup and evaluation of patients with prurigo nodularis. Medicines (Basel). 2019;6(4):97.","journal-title":"Medicines (Basel)"},{"issue":"2","key":"1406_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaad.2019.07.022","volume":"82","author":"HF Stander","year":"2020","unstructured":"Stander HF, Elmariah S, Zeidler C, Spellman M, St\u00e4nder S. Diagnostic and treatment algorithm for chronic nodular prurigo. J Am Acad Dermatol. 2020;82(2):460\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1406_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","volume":"140","author":"AH Huang","year":"2020","unstructured":"Huang AH, Canner JK, Khanna R, Kang S, Kwatra SG. Real-world prevalence of prurigo nodularis and burden of associated diseases. J Invest Dermatol. 2020;140(2):480-483.e484.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"1406_CR4","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1016\/j.jid.2021.02.756","volume":"141","author":"S Wongvibulsin","year":"2021","unstructured":"Wongvibulsin S, Sutaria N, Williams KA, et al. A nationwide study of prurigo nodularis: disease burden and healthcare utilization in the United States. J Invest Dermatol. 2021;141(10):2530-2533.e2531.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1406_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2018.04.044","volume":"79","author":"S Steinke","year":"2018","unstructured":"Steinke S, Zeidler C, Riepe C, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol. 2018;79(3):457-463.e455.","journal-title":"J Am Acad Dermatol"},{"key":"1406_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jdin.2023.07.009","volume":"13","author":"MZ Joel","year":"2023","unstructured":"Joel MZ, Taylor MT, Cornman HL, et al. Risk of incident sleep disorders in patients with prurigo nodularis: a population-level analysis using The Health Improvement Network. JAAD Int. 2023;13:39\u201345.","journal-title":"JAAD Int"},{"issue":"10","key":"1406_CR7","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/jdv.16309","volume":"34","author":"MP Pereira","year":"2020","unstructured":"Pereira MP, Hoffmann V, Weisshaar E, et al. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. J Eur Acad Dermatol Venereol. 2020;34(10):2373\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1406_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajp.2015.07.010","volume":"17","author":"D Konda","year":"2015","unstructured":"Konda D, Chandrashekar L, Rajappa M, Kattimani S, Thappa DM, Ananthanarayanan PH. Serotonin and interleukin-6: association with pruritus severity, sleep quality and depression severity in prurigo nodularis. Asian J Psychiatr. 2015;17:24\u20138.","journal-title":"Asian J Psychiatr"},{"issue":"8","key":"1406_CR9","doi-asserted-by":"publisher","first-page":"adv00119","DOI":"10.2340\/00015555-3471","volume":"100","author":"T Todberg","year":"2020","unstructured":"Todberg T, Zachariae C, Skov L. Treatment and burden of disease in a cohort of patients with prurigo nodularis: a survey-based study. Acta Derm Venereol. 2020;100(8):adv00119.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"1406_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaad.2021.05.036","volume":"86","author":"KA Whang","year":"2022","unstructured":"Whang KA, Le TK, Khanna R, et al. Health-related quality of life and economic burden of prurigo nodularis. J Am Acad Dermatol. 2022;86(3):573\u201380.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1406_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00403-020-02148-0","volume":"313","author":"SR Janmohamed","year":"2021","unstructured":"Janmohamed SR, Gwillim EC, Yousaf M, Patel KR, Silverberg JI. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis. Arch Dermatol Res. 2021;313(8):669\u201377.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"1406_CR12","doi-asserted-by":"publisher","first-page":"adv00403","DOI":"10.2340\/00015555-3726","volume":"101","author":"MP Pereira","year":"2021","unstructured":"Pereira MP, Zeidler C, Wallengren J, et al. Chronic nodular prurigo: a European cross-sectional study of patient perspectives on therapeutic goals and satisfaction. Acta Derm Venereol. 2021;101(2):adv00403.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"1406_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.5114\/ada.2019.84007","volume":"36","author":"K Kaaz","year":"2019","unstructured":"Kaaz K, Szepietowski JC, Matusiak L. Sleep quality among adult patients with chronic dermatoses. Postepy Dermatol Alergol. 2019;36(6):659\u201366.","journal-title":"Postepy Dermatol Alergol"},{"issue":"12","key":"1406_CR14","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1111\/jdv.16696","volume":"34","author":"EC Gwillim","year":"2020","unstructured":"Gwillim EC, Janmohamed SR, Yousaf M, Patel KR, Silverberg JI. The impact of prurigo nodularis on sleep disturbance and related impact: a systematic review. J Eur Acad Dermatol Venereol. 2020;34(12):e815\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"17","key":"1406_CR15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","volume":"389","author":"SG Kwatra","year":"2023","unstructured":"Kwatra SG, Yosipovitch G, Legat FJ, et al. Phase\u00a03 trial of nemolizumab in patients with prurigo nodularis. N Engl J Med. 2023;389(17):1579\u201389.","journal-title":"N Engl J Med"},{"issue":"10","key":"1406_CR16","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jdv.20099","volume":"38","author":"SG Kwatra","year":"2024","unstructured":"Kwatra SG, Yosipovitch G, Stander S, et al. Responder analysis using clinically meaningful thresholds: post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis. J Eur Acad Dermatol Venereol. 2024;38(10):1965\u201372.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1406_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.19800","volume":"38","author":"S Stander","year":"2024","unstructured":"Stander S, Kim BS, Guillemin I, et al. Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. J Eur Acad Dermatol Venereol. 2024;38(7):1401\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1406_CR18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s13555-023-00962-8","volume":"13","author":"S Stander","year":"2023","unstructured":"Stander S, Fofana F, Dias-Barbosa C, et al. The sleep disturbance numerical rating scale: content validity, psychometric validation, and meaningful within-patient change in prurigo nodularis. Dermatol Ther (Heidelb). 2023;13(7):1587\u2013602.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"1406_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/15402002.2016.1173556","volume":"16","author":"KHG Maich","year":"2018","unstructured":"Maich KHG, Lachowski AM, Carney CE. Psychometric properties of the consensus sleep diary in those with insomnia disorder. Behav Sleep Med. 2018;16(2):117\u201334.","journal-title":"Behav Sleep Med"},{"issue":"2","key":"1406_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5665\/sleep.1642","volume":"35","author":"CE Carney","year":"2012","unstructured":"Carney CE, Buysse DJ, Ancoli-Israel S, et al. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012;35(2):287\u2013302.","journal-title":"Sleep"},{"issue":"1","key":"1406_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s41687-020-00265-y","volume":"4","author":"C Dias-Barbosa","year":"2020","unstructured":"Dias-Barbosa C, Matos R, Vernon M, Carney CE, Krystal A, Puelles J. Content validity of a sleep numerical rating scale and a sleep diary in adults and adolescents with moderate-to-severe atopic dermatitis. J Patient Rep Outcomes. 2020;4(1):100.","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"1406_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jamadermatol.2024.4796","volume":"161","author":"S St\u00e4nder","year":"2025","unstructured":"St\u00e4nder S, Yosipovitch G, Legat FJ, et al. Efficacy and safety of nemolizumab in patients with moderate to severe prurigo nodularis: the OLYMPIA\u00a01 randomized clinical phase\u00a03 trial. JAMA Dermatol. 2025;161(2):147\u201356.","journal-title":"JAMA Dermatol"},{"key":"1406_CR23","unstructured":"Food and Drug Administration (FDA). Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments (Docket number FDA-2022-D-1385). 2022."},{"issue":"1","key":"1406_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s41687-024-00751-7","volume":"8","author":"C Dias-Barbosa","year":"2024","unstructured":"Dias-Barbosa C, Silverberg JI, St\u00e4nder S, et al. Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials. J Patient-Rep Outcomes. 2024;8(1):73.","journal-title":"J Patient-Rep Outcomes"},{"issue":"11","key":"1406_CR25","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jamadermatol.2023.3251","volume":"159","author":"D Rodriguez","year":"2023","unstructured":"Rodriguez D, Kwatra SG, Dias-Barbosa C, et al. Patient perspectives on living with severe prurigo nodularis. JAMA Dermatol. 2023;159(11):1205\u201312.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1406_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2340\/00015555-1246","volume":"92","author":"NQ Phan","year":"2012","unstructured":"Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012;92(5):502\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1406_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjd.17744","volume":"181","author":"G Yosipovitch","year":"2019","unstructured":"Yosipovitch G, Reaney M, Mastey V, et al. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis. Br J Dermatol. 2019;181(4):761\u20139.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1406_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"1406_CR29","unstructured":"EuroQol. EQ-5D-3L. https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-3l-about\/. Accessed 23 April 2021."},{"issue":"2","key":"1406_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69\u201377.","journal-title":"J Psychosom Res"},{"issue":"10","key":"1406_CR31","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/jdv.15040","volume":"32","author":"J Polking","year":"2018","unstructured":"Polking J, Zeidler C, Schedel F, et al. Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32(10):1754\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1406_CR32","volume-title":"Psychometric theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC, Bernstein I. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.","edition":"3"},{"key":"1406_CR33","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Routledge; 1988.","edition":"2"},{"key":"1406_CR34","volume-title":"The analysis of variance","author":"H Scheff\u00e9","year":"1999","unstructured":"Scheff\u00e9 H. The analysis of variance. New York: Wiley; 1999."},{"issue":"11","key":"1406_CR35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.euroneuro.2014.08.009","volume":"24","author":"MT Samara","year":"2014","unstructured":"Samara MT, Engel RR, Millier A, Kandenwein J, Toumi M, Leucht S. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS. Eur Neuropsychopharmacol. 2014;24(11):1767\u201372.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"1406_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-023-00818-z","volume":"25","author":"S M\u00fcller","year":"2024","unstructured":"M\u00fcller S, Zeidler C, St\u00e4nder S. Chronic prurigo including prurigo nodularis: new insights and treatments. Am J Clin Dermatol. 2024;25(1):15\u201333.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1406_CR37","doi-asserted-by":"publisher","first-page":"adv00424","DOI":"10.2340\/00015555-3778","volume":"101","author":"EC Gwillim","year":"2021","unstructured":"Gwillim EC, Nattkemper L, Yosipovitch G. Impact of itch on sleep disturbance in patients with prurigo nodularis. Acta Derm Venereol. 2021;101(3):adv00424.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"1406_CR38","first-page":"630","volume":"25","author":"AD Krystal","year":"2002","unstructured":"Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep. 2002;25(6):630\u201340.","journal-title":"Sleep"},{"issue":"1","key":"1406_CR39","doi-asserted-by":"publisher","first-page":"zpac028","DOI":"10.1093\/sleepadvances\/zpac028","volume":"3","author":"T Akerstedt","year":"2022","unstructured":"Akerstedt T, Schwarz J, Lindberg E, Theorell-Haglow J. Total sleep time, sleep efficiency, and next day subjective sleepiness in a large group of women. Sleep Adv. 2022;3(1):zpac028.","journal-title":"Sleep Adv"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01406-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01406-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01406-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T16:48:43Z","timestamp":1747759723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01406-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01406-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"type":"print","value":"2193-8210"},{"type":"electronic","value":"2190-9172"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sonja St\u00e4nder has been a speaker, consultant, investigator, and\/or recipient of research funding from Abbvie, Almirall, Beiersdorf, BMS, Clexio, Eli Lilly, FomF, Galderma, Integrity CE, Kiniksa, Leo Pharma, L\u2019Or\u00e9al, MEDahead, Moroscience, NACCME, Novartis, Omnicuris, P.G. Unna Academy, Pfizer, Sanofi, TouchIME, UCB, Vifor, and WebMD. Shawn G. Kwatra is an advisory board member\/consultant for Abbvie, Aslan Pharmaceuticals, Arcutis Biotherapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte Corporation, Johnson & Johnson, Leo Pharma, Novartis Pharmaceuticals Corporation, Pfizer, Regeneron Pharmaceuticals, and Sanofi and has served as an investigator for Galderma, Incyte, Pfizer, and Sanofi. Dr. Kwatra\u2019s current affiliation is Maryland Itch Center, University of Maryland School of Medicine, Baltimore, MD, USA. Danielle N. Rodriguez, Carla Dias-Barbosa, and Dina Filipenko are employees of Evidera, which was paid by Galderma for work relating to this study. Christophe Piketty, Zarif Jabbar-Lopez, and Jorge Puelles are employees of Galderma, which funded this study. Henning Wiegmann have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethics approval for the qualitative interview study was obtained from Advarra (Columbia, MD; reference number Pro00044847), and participants provided written informed consent before taking part. The OLYMPIA trials were conducted in accordance with the Helsinki Declaration of 1964 and its later amendments, good clinical practice guidelines, and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines. Both trials received ethical approval from applicable regulatory authorities and the independent ethics committee or institutional review board at each participating site before study initiation. All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}